Frontiers in Cell and Developmental Biology (Jun 2023)

Comprehensive analysis of REST corepressors (RCORs) in pan-cancer

  • Rong Zheng,
  • Rong Zheng,
  • Rong Zheng,
  • Yingying Pan,
  • Yingying Pan,
  • Yingying Pan,
  • Xinhui Liu,
  • Xinhui Liu,
  • Xinhui Liu,
  • Feiye Liu,
  • Feiye Liu,
  • Feiye Liu,
  • Aimin Li,
  • Aimin Li,
  • Aimin Li,
  • Dayong Zheng,
  • Dayong Zheng,
  • Dayong Zheng,
  • Yue Luo,
  • Yue Luo,
  • Yue Luo

DOI
https://doi.org/10.3389/fcell.2023.1162344
Journal volume & issue
Vol. 11

Abstract

Read online

REST corepressors (RCORs) are the core component of the LSD1/CoREST/HDACs transcriptional repressor complex, which have been revealed differently expressed in various cancers, but the therapeutic and prognostic mechanisms in cancer are still poorly understood. In this study, we analyzed expression, prognostic value, molecular subtypes, genetic alteration, immunotherapy response and drug sensitivity of RCORs in pan-cancer. Clinical correlation, stemness index, immune infiltration and regulatory networks of RCORs in hepatocellular carcinoma (HCC) were detected through TCGA and GSCA database. In-vitro experiments were conducted to explore the role of RCOR1 in HCC cells. The expression of RCORs varied among different cancers, and have prognostic values in several cancers. Cancer subtypes were categorized according to the expression of RCORs with clinical information. RCORs were significantly correlated with immunotherapy response, MSI, drug sensitivity and genetic alteration in pan-cancer. In HCC, RCORs were considered as potential predictor of stemness and also had association with immune infiltration. The ceRNA-TF-kinase regulatory networks of RCORs were constructed. Besides, RCOR1 acts as an oncogene in HCC and promotes the proliferation of HCC cells by inhibiting cell cycle arrest and cell apoptosis. Taken together, our study revealed the potential molecular mechanisms of RCORs in pan-cancer, offering a benchmark for disease-related research.

Keywords